3 results match your criteria: "Ninth of July University (UNINOVE)[Affiliation]"
Onco Targets Ther
November 2024
Medical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru.
Introduction: Advanced malignant melanoma is a very aggressive disease, historically with poor prognosis before the new advances with immunotherapy and targeted therapies that have changed the standard of care, especially in cutaneous melanoma. Peru has aggressive features such as higher rates of acral lentiginous melanoma (ALM) subtype with historically shorter survival.
Methods: This study describes Peruvian patients with advanced melanoma treated with immunotherapy (nivolumab) in two oncological institutions (public and private), including the discussion of the impact on overall survival (OS) divided by subtype (with incidence in ALM histology) and potential biomarkers that could be related to prognosis.
Minerva Urol Nephrol
February 2024
Ninth of July University (UNINOVE), São Paulo, Brazil -
Introduction: Percutaneous nephrolithotomy (PCNL) is considered the gold standard treatment for kidney stones greater than 20 mm. However, retrograde intrarenal surgery (RIRS) may achieve the same stone-free rate with repeated procedures, and potentially fewer complications. This study aimed to compare the efficacy and safety of PCNL and two-staged RIRS.
View Article and Find Full Text PDFBMC Genomics
April 2021
Department of Structural and Functional Biology, Institute of Biosciences, São Paulo State University - UNESP, Botucatu, Sao Paulo, 18618-970, Brazil.